. List of E. coli Nissle 1917 mutants constructed in this study Table S2 . Primers used in this study (Table S1 ). The recombinase expression plasmid pSC101-BAD-gbaA-tet was removed by culture temperature shift to 42 °C. A list of mutants generated in this study is provided as Table S1 . Oligonucleotides used for gene deletions are listed in Table S2 . An exemplarily example of a diagram for gene inactivation (clbH) by replacement of an antibiotic resistance marker in the chromosome of E. coli Nissle 1917 using Red/ET recombineering is shown in Fig. S1 .
General methods for cultivation and culture extraction for LC-MS analysis
The E. coli strains Nissle 1917 wildtype and verified mutants were incubated in 25 mL Luria broth in 100 mL glass flasks amended with suitable antibiotics at 30℃ (200 rpm) for 2 days. The culture was extracted by 25 mL EtOAc. Twenty mL organic phase was evaporated to dryness. The resulting residue was dissolved in 200 µL of methanol for LC-MS analysis. Standard analysis of crude extracts was performed on a Dionex Ultimate 3000 LC system using a Waters Acquity BEH C-18, 50 x 2 mm, 1.7 μm dp column. Spectrometry (UPLC-HRMS) measurements were performed on a Dionex Ultimate 3000 RSLC system using a Waters BEH C18, 50 x 2.1 mm, 1.7 µm dp column. Separation of 2 µL sample was achieved by a linear gradient with (A) H 2 O + 0.1 % FA to (B) ACN + 0.1 % FA at a flow rate of 600 µL/min and 45 °C.
The gradient was initiated by a 1 min isocratic step at 5 % B, followed by an increase to 95 % B in 6 min to end up with a 1.5 min step at 95 % B before reequilibration with initial conditions. UV spectra were recorded by a DAD in the range from 200 to 600 nm. The LC flow was split to 75 µL/min before entering the maXis4Ghr-ToF mass spectrometer (BrukerDaltonics, Bremen, Germany) using the standard ESI source. Mass spectra were acquired in centroid mode ranging from 150 -2000 m/z at 2 Hz scan speed. 
Isolation of compounds 2 and 3

E. coli
LC-MS Analysis of L/D-FDLA Derivatives
Approximately 0.25 mg of compound was hydrolyzed with 6 N HCl (0.5 mL) for 16 h at 100 °C, dried, and dissolved in H 2 O (100 μL). To a 50 μL aliquot of each were added 1 N NaHCO 3 (20 μL) and 1% 1- extracted by the same volume of EtOAc, the organic layer was dried by Genevac EZ-2 plus, and then redisolved into 50 µL MeOH for LC-MS measurement. Standard analysis of crude extracts was performed on a Dionex Ultimate 3000 LC system using a Waters Acquity BEH C-18, 50 x 2 mm, 1.7 μm dp column. Separation of a 2 μL sample was achieved by a linear gradient with (A) H2O + 0.1 % FA to (B) ACN + 0.1 % FA at a flow rate of 0.6 mL/min and 45 °C. The gradient was initiated by a 0.5 min isocratic step at 5 % B, followed by an increase to 95 % B in 9 min to end up with a 1.5 min step at 95 % B before reequilibration with initial conditions. UV spectra were recorded by a DAD in the range from 200 to 600 nm. The MS measurement was carried on an amaZon speed mass spectrometer (BrukerDaltonics, Bremen, Germany) using the standard ESI source. Mass spectra were acquired in centroid mode ranging from 200 -2000 m/z in positive ionization mode with auto MS2 fragmentations.
UPLC-HRMS was done on Accela UPLC-system (Thermo-Fisher) coupled to a linear trap-FT-Orbitrap combination (LTQ-Orbitrap) in positive ionization mode with a Waters BEH RP-C18 column (50 x 2 mm; 1.7 µm particle diameter, flow rate 0.6 mL/min) with a mobile phase of H 2 O/ACN each containing 0.1% of FA, using a gradient from 5-95% of ACN over 9 min.
Antibacterial activity test
The activity measurement was same to the description on references. 8;9 The DMSO stocks of compounds 2 and 3 were serially diluted in Müller Hinton broth. OD 600 was measured after 4, 8, 16 h of treatment and the starting OD was 0.01, which corresponds to approximate 5 x 10 6 cfu/mL. Two bacteria Bacillus subtilis DSM-10 (DSMZ) and E. coli (TolC-deficient) (Internal Strain Collection) were tested in this study. Table S2 Ref. TGACAATAATGGAACACGTTAGCATTAAAACATTATATCATCTCCTGTGCTGTATACC  TGTGACGGAAGATCACTTC  clbP-cm3  TAGAATTCGTTTAATTTGATGATTTAATGTCAGAACGAAAGCTAACAGGATAATTACG  CCCCGCCCTGCCACTC  clbP-ch5  TGGAGAAAACCTGGCGTTCATTG  clbP-ch3  TCAGCGACGGCATCCACCATC  clbH-km5  TATGGAACAGCAAGGGATTATGAGACAGTTGCCTACCGACGACCAAACGCTCGAGCT  ACTGGGCTATCTG  clbH-km3  TCAGTGATGACTGTCGGTTGTGGCTGCCCAGCGCGTGTGACCAAAGGCCATCAGAAGA  ACTCGTCAAGAAG  km-ch1  TCATAGCCGAATAGCCTCTCC  km-ch2  TGCCTGCTTGCCGAATATCATG  clbH-ch1  TGGTGCTGGGGGATAACATG  clbH-ch2  TAGCCCGCATCTTCGAAGGCTG  clbJ-km5  TCATGACGATACATCATGCCGCATTGGCGCGAATGTTACCGGCGGAACTCGAGCTACT  GGGCTATCTGGAC  clbJ-km3  TAACGCTGACGCTGGTGACGACGTACAAGTCGTTGCTGGGCGCGGGATCGTCAGAAG  AACTCGTCAAGAAGG  clbJ-ch1  TGTCATCCCTAGCGAACCGTC  clbJ-ch2  TGGTACTCACGCCCGCATATAG  clbK-km5  TGACTTACAGTGAAAGCGATATTGCCATTGTTGGCATGAACTGCCGGTACTCGAGCTA  CTGGGCTATCTGGAC  clbK-km3  TACGCCGCAACGCCAGATTCTCGCGCGCAGCGCTGACCTGCGAAACCTCATCAGAAG  AACTCGTCAAGAAGG  clbK-ch1  TCTACATCACAGAAGTCGAGGG  clbK-ch2  TAAGCGTGCGATGGAAGGAG  clbC-km5  TATGGAATACGCAAGCGAAATGAACGGCATGGAAATCGCCATTATTGGTACTCGAGC  TACTGGGCTATCTG  clbC-km3  TACTGACAGGCTATTTCGAGGTTGTCTTCGCCCCCCAGTTGCGCCGCGATCAGAAGAA  CTCGTCAAGAAGG  clbC-ch1  TCCTGGAAGAGTATCTGGGTC  clbC-ch2  TCGACGCGCCGCAGATCGTATTC  clbI-km5  TGGCAGAGAATGATTTTGGTATAGCTATCATTGGGATGGCGGGGCGTTTCCTCGAGCT   ACTGGGCTATCTGG  clbI-km3  TCATTAATCATGTCGTTAACTAGCACGGCAAGTGCGGACCCTCCATCATCAGAAGAAC  TCGTCAAGAAGG  clbI-ch1  TCTTCGATCTCGGTGGACACTC  clbI-ch2  TACCGCATCTAGCGCTGAAGTTG  clbO-km5  TGGCAAAGGATGATTTTACCTGTGGCTCACTGGATATTGCCATTATTGGCCTCGAGCT  ACTGGGCTATCTGG  clbO-km3  TACCATCAACACATTCGGAGATAAATTCACTGTGCTCACGGATAGCTCAGAAGAACTC  GTCAAGAAGG 
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Sequence of homology arms for recombineering are underlined. 
